I was diagnosed with Her 2 : 3 positive for breast cancer in January 2023. Started chemotherapy with Paclitaxal weekly and injection Phesgo once in 3 weeks. My insurance company National Isiramve denies reimbursement for Phesgo calling it as a modern medicine. I was made to understand Phesgo with chemotherapy is covered by insurance.
Now I have had surgery and have been advised Herceptin Trastuzumab which is administered to prevent the recurrence Of cancer cells
I was made to believe that Herceptin Trastuzumab are required for a full and effective recovery of HER2 Positive
Breast Cancer Patients.
Why is this too denied by insurance company How is one suppose to bear the cost of the treatment as well pay premium to the insurance company
Any help n suggestions are most welcome